JPRN-UMIN000023200
Completed
Phase 4
The study of Intravitreal aflibercept with treat and extend regimen for macular edema with branch retinal vein occlusion (BRVO) - The study of aflibercept with treat and extend regimen for BRVO
Department of Ophthalmology, Akita University0 sites50 target enrollmentSeptember 1, 2016
ConditionsBranch retinal vein occlusion
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Branch retinal vein occlusion
- Sponsor
- Department of Ophthalmology, Akita University
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. History of vitrectomy or glaucoma surgery 2\. Other disorders such as DME, CRVO or idiopathic macular telangiectasia 3\. Poor control hypertension (systolic pressure \>180mmHg, diastolic pressure \>100mmHg) 4\. Concomitant conditions/diseases including uncontrolled glaucoma and intraocular inflammation 5\. Patients who the doctor in charge judges are ineligible for the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
The efficacy of intravitreal aflibercept given in a ‘treat and extend’ regime in the treatment of cystoid macular oedema secondary to central retinal vein occlusion.central retinal vein occlusion (CRVO).cystoid macular oedemaEye - Diseases / disorders of the eyeACTRN12615000417583Centre for Eye Research Australia20
Completed
Not Applicable
Efficacy evaluation of intravitreal aflibercept for polypoidal choroidal vasculopathyJPRN-UMIN000010461Yokohama City University Medical Center30
Active, not recruiting
Not Applicable
Optical Coherence Tomography Angiography Biomarkers in a Bi-monthly Maintenance Dosing Aflibercept in Patients with Neovascular Age-Related Macular DegeneratioDiseases of the eye and adnexaKCT0007375Kyung Hee University Hospital40
Completed
Not Applicable
Effect of Intravitreal Aflibercept Injection on Microaneurysm in Patients with Diabetic Macular EdemaJPRN-UMIN000018315Department of Ophthalmology, Mie University30
Active, not recruiting
Phase 1
The Effect of Intravitreal Aflibercept on Ocular Perfusion – a Pilot StudyExudative AMDMedDRA version: 19.1Level: LLTClassification code 10025411Term: Macular degeneration senileSystem Organ Class: 100000004853Therapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2016-004608-78-ATKepler University Hospital, Institute of Ophthalmology